Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/2663
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKimaiyo Sylvester-
dc.contributor.authorPaula Braitstein-
dc.contributor.authorSiika Abraham-
dc.contributor.authorHogan Joseph W-
dc.contributor.authorSang Edwin-
dc.contributor.authorKosgei Rose-
dc.contributor.authorSidle John-
dc.contributor.authorKara K Wools-Kaloustian-
dc.contributor.authorKeter Alfred-
dc.contributor.authorMamlin Joseph-
dc.date.accessioned2019-02-06T07:59:59Z-
dc.date.available2019-02-06T07:59:59Z-
dc.date.issued2012-02-17-
dc.identifier.urihttp://ir.mu.ac.ke:8080/xmlui/handle/123456789/2663-
dc.description.abstractBackground In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. Methods The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm3. All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm3 were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. Results Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm3. After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). Conclusions Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings.en_US
dc.language.isoenen_US
dc.publisherJournal of the International AIDS Societyen_US
dc.subjectAntiretroviralsen_US
dc.subjectMortalityen_US
dc.subjectLosses to follow upen_US
dc.subjectAdherenceen_US
dc.subjectModels of careen_US
dc.subjectAfricaen_US
dc.titleA clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatmenten_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
Kimaiyo Slyvester 2012314.78 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.